Edward Kosinski, a cardiologist at Cardiology Physicians in Bridgeport, CT and the Medical Director of Connecticut Clinical Analysis LLC, where the first patients have been enrolled. This study can help us to determine if MTWA can identify blood flow problems and also electrical problems in the heart. The MTWA-CAD trial is a pilot research expected to enroll up to 200 patients. The ongoing company estimates that the enrollments will be completed by mid-2011. This study is an important first step in determining if MTWA might help identify hidden ischemia in sufferers with suspected coronary artery disease, said Ali Haghighi-Mood, Cambridge Heart’s Chief Executive Officer.Sankaran to get Rising Celebrity Award New York-Presbyterian /Columbia can be a premier cardiovascular treatment institution, stated Christopher P. Cannon, MD, board person in the Society of Upper body Discomfort Centers, cardiologist at Brigham & Women’s Medical center, and Associate Professor of Medication at Harvard University. The Society’s Chest Pain Middle accreditation recognizes their dedication and dedication to excellent care.